India
# |
Name |
Debt to Equity Ratio |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
4.17
|
March 31, 2024 | USD 2.75 | 4.60% |
|
India |
|
2 |
2.05
|
March 31, 2024 | USD 1.36 | 1.47% |
|
India |
|
3 |
2.02
|
March 31, 2024 | USD 11.85 | 8.40% |
|
India |
|
4 |
1.54
|
March 31, 2024 | USD 0.76 | 4.35% |
|
India |
|
5 |
1.54
|
March 31, 2024 | USD 5.77 | 2.41% |
|
India |
|
6 |
1.34
|
March 31, 2024 | USD 12.71 | -1.99% |
|
India |
|
7 |
1.28
|
March 31, 2024 | USD 0.63 | 2.72% |
|
India |
|
8 |
1.20
|
March 31, 2024 | USD 6.30 | 3.70% |
|
India |
|
9 |
1.18
|
March 31, 2024 | USD 7.21 | 1.18% |
|
India |
|
10 |
1.09
|
March 31, 2024 | USD 2.61 | 3.51% |
|
India |
|
11 |
1.08
|
March 31, 2024 | USD 7.64 | 4.37% |
|
India |
|
12 |
1.08
|
March 31, 2024 | USD 14.77 | 2.53% |
|
India |
|
13 |
1.06
|
March 31, 2024 | USD 11.43 | 7.80% |
|
India |
|
14 |
0.98
|
March 31, 2024 | USD 6.45 | 3.14% |
|
India |
|
15 |
0.93
|
March 31, 2024 | USD 0.32 | -5.51% |
|
India |
|
16 |
0.91
|
March 31, 2024 | USD 5.40 | 1.57% |
|
India |
|
17 |
0.89
|
March 31, 2024 | USD 6.92 | 3.83% |
|
India |
|
18 |
0.86
|
March 31, 2024 | USD 1.81 | 2.73% |
|
India |
|
19 |
0.85
|
March 31, 2024 | USD 1.25 | 3.53% |
|
India |
|
20 |
0.84
|
March 31, 2024 | USD 25.74 | 1.82% |
|
India |
|
21 |
0.82
|
March 31, 2024 | USD 1.81 | 5.67% |
|
India |
|
22 |
0.82
|
March 31, 2024 | USD 4.48 | 6.30% |
|
India |
|
23 |
0.79
|
March 31, 2024 | USD 1.50 | 6.33% |
|
India |
|
24 |
0.79
|
March 31, 2024 | USD 1.20 | 2.50% |
|
India |
|
25 |
0.78
|
March 31, 2024 | USD 0.73 | 1.01% |
|
India |
|
26 |
0.77
|
March 31, 2024 | USD 77.49 | -1.80% |
|
India |
|
27 |
0.74
|
March 31, 2024 | USD 2.07 | 5.03% |
|
India |
|
28 |
0.74
|
March 31, 2024 | USD 7.15 | 0.36% |
|
India |
|
29 |
0.72
|
March 31, 2024 | USD 0.36 | 6.21% |
|
India |
|
30 |
0.70
|
March 31, 2024 | USD 15.79 | 3.81% |
|
India |
|
31 |
0.69
|
March 31, 2024 | USD 2.34 | 3.08% |
|
India |
|
32 |
0.69
|
March 31, 2024 | USD 4.21 | 4.98% |
|
India |
|
33 |
0.67
|
March 31, 2024 | USD 11.12 | 4.25% |
|
India |
|
34 |
0.64
|
March 31, 2024 | USD 8.96 | -4.78% |
|
India |
|
35 |
0.63
|
March 31, 2024 | USD 6.56 | 1.75% |
|
India |
|
36 |
0.63
|
March 31, 2024 | USD 5.42 | -1.33% |
|
India |
|
37 |
0.61
|
March 31, 2024 | USD 4.73 | 0.12% |
|
India |
|
38 |
0.61
|
March 31, 2024 | USD 16.98 | -3.69% |
|
India |
|
39 |
0.61
|
March 31, 2024 | USD 3.76 | 0.04% |
|
India |
|
40 |
0.60
|
March 31, 2024 | USD 2.71 | 1.14% |
|
India |
|
41 |
0.59
|
March 31, 2024 | USD 0.44 | 2.12% |
|
India |
|
42 |
0.59
|
March 31, 2024 | USD 37.58 | 0.68% |
|
India |
|
43 |
0.57
|
March 31, 2024 | USD 41.96 | 0.53% |
|
India |
|
44 |
0.57
|
March 31, 2024 | USD 14.90 | 4.46% |
|
India |
|
45 |
0.57
|
March 31, 2024 | USD 3.99 | -4.57% |
|
India |
|
46 |
0.56
|
March 31, 2024 | USD 14.93 | 1.77% |
|
India |
|
47 |
0.54
|
March 31, 2024 | USD 23.80 | 5.93% |
|
India |
|
48 |
0.52
|
March 31, 2024 | USD 2.55 | 2.90% |
|
India |
|
49 |
0.52
|
March 31, 2024 | USD 9.00 | 6.34% |
|
India |
|
50 |
0.49
|
March 31, 2024 | USD 2.08 | 3.06% |
|
India |
The Pharmaceuticals company in India with the highest Debt to Equity Ratio is Wanbury Limited (NSE: WANBURY.NS) at 4.17.
The Pharmaceuticals company in India with the lowest Debt to Equity Ratio is TAKE Solutions Limited (NSE: TAKE.NS) at -4.18.
The top 10 Pharmaceuticals companies in India by Debt to Equity Ratio are Wanbury Limited, Bal Pharma Limited, Piramal Enterprises Limited, NACL Industries Limited, HealthCare Global Enterprises Limited, Astec LifeSciences Limited, Vineet Laboratories Limited, Bajaj HealthCare Limited, Strides Pharma Science Limited and Uttam Sugar Mills Limited.
The bottom 10 Pharmaceuticals companies in India by Debt to Equity Ratio are TAKE Solutions Limited, Krebs Biochemicals & Industries Limited, Ind-Swift Limited, Kaya Limited, Jupiter Life Line Hospitals Limited, RPG Life Sciences Limited, Diamines and Chemicals Limited, The United Nilgiri Tea Estates Company Limited, Universus Photo Imagings Limited and Divi's Laboratories Limited.